ArticleBiosensors & bioelectronics2021
5G-enabled ultra-sensitive fluorescence sensor for proactive prognosis of COVID-19.
Article in Biosensors & bioelectronics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
56 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- Mobile Apps for COVID-19 Detection and Diagnosis for Future Pandemic Control: Multidimensional Systematic Review.JMIR mHealth and uHealth · 2024Pooled it
- A Systematic Review of Internet of Things in Clinical Laboratories: Opportunities, Advantages, and Challenges.Sensors (Basel, Switzerland) · 2022Pooled it
- Updating the use of nano-biosensors as promising devices for the diagnosis of coronavirus family members: A systematic review.Journal of pharmaceutical and biomedical analysis · 2022Pooled it
- Advances in fluorescence-based point-of-care diagnostics: probes, nanostructures and integrated systems.Journal of materials chemistry. C · 2026Review
- Privacy preserving optimization of communication networks.Nature communications · 2025Article
- Energy-efficient communication between IoMT devices and emergency vehicles for improved patient care.PloS one · 2025Article
- Fast and Sensitive Detection of Anti-SARS-CoV-2 IgG Using SiOBiomolecules · 2024Article
- Climate change, its impact on emerging infectious diseases and new technologies to combat the challenge.Emerging microbes & infections · 2024Review
- Luminescent photon-upconversion nanoparticles with advanced functionalization for smart sensing and imaging.Mikrochimica acta · 2024Review
- Convenient two-step method constructed silicon-based microfluidic chip for fast CYP2C19 SNPs detection.RSC advances · 2024Article
- Cold-Responsive Hyaluronated Upconversion Nanoplatform for Transdermal Cryo-Photodynamic Cancer Therapy.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024Article
- Efficient Connectivity in Smart Homes: Enhancing Living Comfort through IoT Infrastructure.Sensors (Basel, Switzerland) · 2024Article
- Coronavirus Anatomy and Its Analytical Approaches for Targeting COVID-19.Advances in experimental medicine and biology · 2024Review
- Highly sensitive digital detection of SARS-CoV-2 nucleocapsid protein through single-molecule counting.Analytical and bioanalytical chemistry · 2023Article
- Advancements in Passive Wireless Sensors, Materials, Devices, and Applications.Sensors (Basel, Switzerland) · 2023Review
- Advanced Mobile Communication Techniques in the Fight against the COVID-19 Pandemic Era and Beyond: An Overview of 5G/B5G/6G.Sensors (Basel, Switzerland) · 2023Review
- Artificial intelligence reinforced upconversion nanoparticle-based lateral flow assay via transfer learning.Fundamental research · 2023Article
- Engineering Innovative Interfaces for Point-of-Care Diagnostics.Current opinion in colloid & interface science · 2023Review
- Portable sensing devices for smart healthcare and prevention of lead poisoning.Journal of the Chinese Medical Association : JCMA · 2023Review
- Internet-of-medical-things integrated point-of-care biosensing devices for infectious diseases: Toward better preparedness for futuristic pandemics.Bioengineering & translational medicine · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is spreading around the globe since December 2019. There is an urgent need to develop sensitive and online methods for on-site diagnosing and monitoring of suspected COVID-19 patients. With the huge development of Internet of Things (IoT), the impact of Internet of Medical Things (IoMT) provides an impressive solution to this problem. In this paper, we proposed a 5G-enabled fluorescence sensor for quantitative detection of spike protein and nucleocapsid protein of SARS-CoV-2 by using mesoporous silica encapsulated up-conversion nanoparticles (UCNPs@mSiO
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.